Uncategorised - European Medical Journal

Managing Factor Xa Inhibitors Perioperatively: PERIXa Shows Promise

New study finds the PERIXa protocol for perioperative anticoagulation in AF patients undergoing low-risk procedures is safe.

Exploring Bladder Preservation in Muscle-Invasive Bladder Cancer Treatment

The combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible and safe treatment strategy.

Early Lung Function Decline Predicts Long-Term Respiratory Symptoms

Individuals with impaired lung function trajectories experience a higher burden of respiratory symptoms, including wheeze and phlegm.

New Evidence Supports PPI Co-Prescription in Patients with AMI Undergoing PCI

PPIs significantly reduce gastrointestinal bleeding risk in AMI patients on DAPT without increasing cardiovascular events. Read more on clinical implications.

High-Risk Genetic Markers Predict Poor Outcomes in Multiple Myeloma

Multiple myeloma patients with two or more high-risk genetic abnormalities face significantly poorer outcomes, regardless of disease stage or treatment.

Study Shows Primary Care and Telehealth Can Provide Effective Diabetes Care

People with Type 1 diabetes can achieve the same positive outcomes using advanced insulin technology when trained by their PCPs or through telehealth as they would by visiting a specialist in person according to new study.

Evaluating Dupilumab for Peanut Allergy Desensitisation in Children

A proof-of-concept study was conducted to explore whether dupilumab could induce desensitisation to peanut in children with peanut allergy.

Minimal Monitoring HCV Treatment Improves QoL for Patients

A recent global study found significant improvements in health-related quality of life (HQoL) among individuals with Hepatitis C (HCV) treated with direct-acting antivirals (DAAs) under a minimal monitoring (MINMON) approach.

Patient Perceptions of AI in Dermatology: Narrative Review

Artificial intelligence (AI) is becoming a key tool in skin cancer diagnosis, but patient acceptance remains a critical aspect of its implementation.

New McDonald Criteria Expand MS Diagnoses: ACTRIMS 2025

New findings presented at the ACTRIMS Forum 2025 highlight how the latest revisions to the McDonald Criteria could reshape the diagnosis of multiple sclerosis (MS), allowing for earlier identification in patients with radiologically isolated syndrome (RIS) and atypical clinical presentations.